Use of the Computer Automated Structure Evaluation program in determining quantitative structure-activity...

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Phenylalkylamines are known for their hallucinogenic properties.
• Understanding the structural basis of this activity is crucial for drug design and safety.

Purpose of the Study:

• To identify molecular fragments in phenylalkylamines associated with hallucinogenic activity using computational methods.
• To develop a Quantitative Structure-Activity Relationship (QSAR) model for predicting the potency of these compounds.

Main Methods:

• Application of the Computer Automated Structure Evaluation (CASE) program to identify key molecular fragments.
• Generation of a QSAR equation based on the identified fragments.
• Prediction of compound potencies using the developed QSAR model.

Main Results:

• The CASE program successfully generated and identified molecular fragments linked to hallucinogenic effects.
• A QSAR equation was derived, demonstrating predictive capabilities for compound potency.
• Correlations between identified fragments and biological activity were established.

Conclusions:

• The CASE program is effective in identifying structure-activity relationships for hallucinogenic phenylalkylamines.
• QSAR modeling based on CASE-identified fragments provides a valuable tool for predicting drug potency.
• This approach aids in understanding and potentially designing safer psychoactive compounds.